Peter Pappas, IDWeek 2021: Unmet needs in the treatment of Candida infections
It was a pleasure to meet with Prof. Peter Pappas (University of Alabama at Birmingham, Birmingham, AL, USA) to discuss the unmet needs in the treatment of Candida infections.
The abstract entitled: ‘Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)’ was presented at IDWeek 2021 (Virtual), 28 September – 3 October 2021.
- Could you give us an overview of the health burden of Candida infections? (0:34)
- What are the unmet needs in the treatment of Candida infections? (2:26)
Disclosures: Peter Pappas receives research support from Cidara, Mayne, Astellas, Gilead and Scynexis; and is also a Scientific advisor for Scynexis, Matinas and F2G.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of IDWeek, Virtual 2021
Share this Video
Related Videos In Fungal Infections
Kayla Stover Hielscher, IDWeek 2022: Isavuconazole – a good treatment option for Candida species?
Isavuconazole is a once-daily antifungal, used to treat a wide array of fungal infections. In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss isavuconazole’s properties and the efficacy and safety compared to other treatment options. The abstract entitled: ‘This Drug for […]
Martin Hoenigl, IDWeek 2022: Candidemia prognosis and unmet needs in its treatment
Candidemia is the one of the most common form of invasive candidiasis, and in some countries the most common causes of bloodstream infections in hospitalized patients. In this touchINFECTIOUS DISEASES interview, we met with Dr Martin Hoenigl (Medical University of Graz, Austria) to discuss the prognosis of candidemia, the unmet needs in its treatment, and […]
Martin Hoenigl, IDWeek 2022: Guideline adherence predicts outcomes of candidemia in Europe
In this touchINFECTIOUS DISEASES interview, we met with Dr Martin Hoenigl (Medical University of Graz, Austria) to discuss ECMM Candida III Multinational European study, which collected data on epidemiology, risk factors, treatment, and outcomes of culture proven candidemia across Europe, to assess how adherence to guideline recommendations correlate with outcomes. The abstract entitled: ‘Guideline Adherence […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!